HolderBook

SALARIUS PHARMACEUTICALS INC (SLRX)

Institutional ownership reported to the SEC as of Q1 2024, across 19 quarters.

13
Reporting holders
$102.0K
Reported value
0.0%
Calls
0.0%
Puts
-3
Holder change

Calls and puts are the parts of reported value carried in derivative lines rather than shares, and they point in opposite directions: a manager holding calls is positioned for the security, one holding puts against it - or hedging shares they already own, which is why index funds carry so many. Most sites add the two together and report one figure, which averages away the only interesting part.

Holders

Download these holders as CSV

FilerValueShares Their book Held Change
ARMISTICE CAPITAL, LLC$44.4K84,0000.00%4q-4.5%-$2.1K
HORIZON KINETICS ASSET MANAGEMENT LLC$16.4K31,0940.00%5qHELD
RENAISSANCE TECHNOLOGIES LLC$15.0K28,2420.00%6q+6.8%
GEODE CAPITAL MANAGEMENT, LLC$13.1K24,7710.00%6qHELD
VANGUARD GROUP INC$7.7K14,5630.00%6qHELD
Tower Research Capital LLC (TRC)$4.5K8,4220.00%4q+2.9%
OSAIC HOLDINGS, INC.$7331,3870.00%6qHELD
MORGAN STANLEY$961800.00%6q+50.0%
WELLS FARGO & COMPANY/MN$16310.00%6q+3.3%
UBS Group AG$10180.00%6q-76.9%
BANK OF AMERICA CORP /DE/$8160.00%3qHELD
BlackRock Inc.$8150.00%6q-68.1%
FMR LLC$470.00%5q-78.8%

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q1 202413$102.0K192,7460440.0%
Q4 202316$169.8K262,7652450.0%
Q3 202314$226.8K344,3061610.0%
Q2 202314$321.5K215,4984330.0%
Q1 202311$186.1K97,4843320.0%
Q4 20228$110.9K72,6908000.0%
Q3 202219$671.0K3,442,0920260.0%
Q2 202223$859.0K4,095,8594740.0%
Q1 202225$1.4M3,641,7687240.0%
Q4 202124$2.6M5,310,2243750.0%
Q3 202125$6.8M6,709,2817540.0%
Q2 202129$10.8M10,166,4205990.0%
Q1 202131$22.8M15,480,651121310.0%
Q4 202024$4.0M4,421,0127530.0%
Q3 202017$630.0K746,9006220.0%
Q2 202013$637.0K483,0111330.0%
Q1 202016$533.0K781,7424320.0%
Q4 201912$909.0K241,1722140.0%
Q3 201912$1.4M256,17812000.0%